Europe Medical Cannabis Market Report 2024-2032: Industry Size, Growth Research
Europe Medical Cannabis Market 2024-2032
According to IMARC Group's report titled "Europe Medical Cannabis Market Report by Species (Indica, Sativa, Hybrid), Derivative (Cannabidiol (CBD), Tetrahydrocannabinol (THC), and Others), Application (Cancer, Arthritis, Migraine, Epilepsy, and Others), End Use (Pharmaceutical Industry, Research and Development Centers, and Others), Route of Administration (Oral Solutions and Capsules, Smoking, Vaporizers, Topicals, and Others), and Country 2024-2032", the report presents a thorough review featuring the market share, growth, share, trends, and research of the industry.
How Big is the Europe Medical Cannabis Industry ?
The Europe medical cannabis market size reached USD 2,167.8 Million in 2023. Looking forward, IMARC Group expects the market to reach USD 11,093.7 Million by 2032, exhibiting a growth rate (CAGR) of 19.3% during 2024-2032.
Europe Medical Cannabis Market Trends:
The market for medical cannabis in Europe is expanding rapidly due to changing laws, growing acceptance of cannabis-based medicines, and an increase in demand for complementary therapies. The progressive legalization of medical cannabis in several European nations is one of the primary drivers driving the market. Cannabis is being more widely used in the healthcare system as a result of governments realizing its potential therapeutic benefits for ailments like multiple sclerosis, chronic pain, epilepsy, and cancer-related symptoms.
Furthermore, the increasing amount of studies showing how well cannabinoids work to treat a range of illnesses is encouraging more acceptance among doctors and patients. The growing need for medicinal cannabis as a treatment alternative is also being fueled by Europe's aging population and rising rates of chronic illnesses.
Request Free Sample Report: https://www.imarcgroup.com/europe-medical-cannabis-market/requestsample
Europe Medical Cannabis Market Scope and Growth Analysis:
In order to meet a variety of medicinal demands, the European medical cannabis market offers a wide range of products, including raw flowers, tinctures, oils, and capsules. According to market research, the legislative environment is changing quickly as more nations investigate the possibility of legalizing medicinal cannabis and increasing patient access. Cannabis businesses from both domestic and foreign countries are finding it easier to access the European market as a result of this regulation change. Additionally, as they strive to create novel formulations and standardized dosages, collaborations between pharmaceutical corporations and cannabis producers are expanding.
A combination of well-known pharmaceutical companies and up-and-coming cannabis businesses define the competitive environment, which places a high priority on R&D. As the market matures, challenges such as stringent regulatory requirements, complex distribution networks, and patient education remain, but the overall outlook for the Europe medical cannabis market is positive, with sustained growth expected as more countries adopt progressive cannabis policies.
Europe Medical Cannabis Industry Segmentation:
The market report offers a comprehensive analysis of the segments, highlighting those with the largest Europe medical cannabis market share. It includes forecasts for the period 2024-2032 and historical data from 2018-2023 for the following segments.
Breakup by Species:
- Indica
- Sativa
- Hybrid
Breakup by Derivative:
- Cannabidiol (CBD)
- Tetrahydrocannabinol (THC)
- Others
Breakup by Application:
- Cancer
- Arthritis
- Migraine
- Epilepsy
- Others
Breakup by End Use:
- Pharmaceutical Industry
- Research and Development Centers
- Others
Breakup by Route of Administration:
- Oral Solutions and Capsules
- Smoking
- Vaporizers
- Topicals
- Others
Breakup by Country:
- Germany
- France
- United Kingdom
- Italy
- Spain
- Others
Competitor Landscape:
The report offers an in-depth examination of the competitive landscape. It includes a thorough competitive analysis encompassing market structure, key player positioning, leading strategies for success, a competitive dashboard, and a company evaluation quadrant.
Ask Analyst For Customization: https://www.imarcgroup.com/request?type=report&id=3059&flag=C
Other key areas covered in the report:
- COVID-19 Impact on the Market
- Porter’s Five Forces Analysis
- Strategic Recommendations
- Market Dynamics
- Historical, Current and Future Market Trends
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain Analysis
- Comprehensive Mapping of the Competitive Landscape
- Top Winning Strategies
- Recent Industry News
- Key Technological Trends & Development
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us:
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services.
IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: [email protected]
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145